Nuveen LLC’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.02M Sell
135,068
-5,061
-4% -$75.8K ﹤0.01% 2293
2025
Q1
$2.26M Buy
+140,129
New +$2.26M ﹤0.01% 2292